Whether or not the ANC and DA can find common ground on the future of medical schemes is set to be a major test of South Africa’s Government of National Unity. Ahead of a Cabinet lekgotla where the issue is expected to be on the agenda, momentum has been gathering behind a compromise option. Chris Bateman reports.
From the ongoing political and legal battles over NHI, to the far-reaching health impacts of political change in the United States, it is set to be another tumultuous year for healthcare in South Africa and around the globe. Here’s Spotlight’s top four healthcare questions for 2025.
From the NHI Act to major advances in HIV prevention, it has been another busy year in the world of healthcare. Spotlight editors Marcus Low and Adiel Ismail recap the year’s health developments and identify some key trends in fewer than 1 000 words.
Ukwanda, the isiXhosa word for “grow,” encapsulates the mission of Stellenbosch University’s Ukwanda Centre for Rural Health: nurturing healthcare in rural communities. At the centre’s annual community partnership event in Worcester, Sue Segar discovered how future healthcare professionals are stepping up to address the unique challenges of rural populations.
The Democratic Alliance intends to propose legislation that would allow healthcare professionals to do community service and internships in private hospitals. Such a legislative change risks exacerbating some of South Africa’s healthcare inequalities, argues Bulela Vava.
Though several South African companies are producing HIV and TB medicines, the active ingredients that go into these medicines are usually imported from India or China. Now, a local company is planning to break new ground by making the active ingredients for two important TB medicines in Pretoria. Catherine Tomlinson zooms in on the company’s efforts and outlines some of the obstacles to getting such local production off the ground.
Several opposition politicians and commentators have flagged what appears to be chronic leadership problems at the Gauteng Department of Health. Ufrieda Ho reports.
Ahead of World AIDS Day 2024, Professor Salim Abdool Karim and Dr Nikita Devnarain argue that South Africa needs a concerted effort to reduce new HIV infections in young women and to prepare for the rollout of long-acting forms of HIV prevention alongside a well-functioning HIV treatment programme.
Whether or not someone living with HIV in South Africa gets a one- or three-months’ supply of antiretrovirals at a time depends partly on the clinic where they happen to go for HIV care. Ahead of World AIDS Day 2024, Elri Voigt unpacks the legal and policy issues relating to prescriptions and HIV medicine refills and asks why people living with HIV are treated so differently in different parts of the country.
HIV prevention injections that can provide two, or even six, months of protection per shot have arguably been the biggest HIV story of the year. Ahead of World AIDS Day, Professor Francois Venter assesses the state of play and the critical next steps with these potentially game-changing new tools in the fight against HIV.
It’s acknowledged in key policy documents, well known at the coalface and much ventilated in the media: South Africa’s public healthcare system has too few healthcare workers, especially medical doctors, certain specialists, and theatre nurses. Less recognised however is the shortage of public sector pharmacists. Chris Bateman lifts the lid on this until now largely hidden problem – and its impact.
There is a history of competition law being used to drive HIV medicine prices lower in South Africa. Now, two cases involving cancer medicines seem set to nail down what qualifies as “excessive pricing” in South African law – a legal development that could have far reaching implications for medicines prices in the country. Catherine Tomlinson unpacks the details.
